KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbCellera Biologics (ABCL) Retained Earnings: 2020-2025

Historic Retained Earnings for AbCellera Biologics (ABCL) over the last 5 years, with Sep 2025 value amounting to -$20.5 million.

  • AbCellera Biologics' Retained Earnings fell 113.59% to -$20.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$20.5 million, marking a year-over-year decrease of 113.59%. This contributed to the annual value of $116.9 million for FY2024, which is 58.21% down from last year.
  • Per AbCellera Biologics' latest filing, its Retained Earnings stood at -$20.5 million for Q3 2025, which was down 156.14% from $36.6 million recorded in Q2 2025.
  • In the past 5 years, AbCellera Biologics' Retained Earnings ranged from a high of $456.1 million in Q3 2022 and a low of -$20.5 million during Q3 2025.
  • Its 3-year average for Retained Earnings is $195.0 million, with a median of $202.2 million in 2024.
  • Its Retained Earnings has fluctuated over the past 5 years, first soared by 134.38% in 2021, then slumped by 113.59% in 2025.
  • Over the past 5 years, AbCellera Biologics' Retained Earnings (Quarterly) stood at $267.7 million in 2021, then spiked by 59.22% to $426.2 million in 2022, then slumped by 34.35% to $279.8 million in 2023, then tumbled by 58.21% to $116.9 million in 2024, then plummeted by 113.59% to -$20.5 million in 2025.
  • Its Retained Earnings stands at -$20.5 million for Q3 2025, versus $36.6 million for Q2 2025 and $71.3 million for Q1 2025.